Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
9
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Duloxetine Sandoz
Treatment in adults of major depressive disorder, diabetic peripheral neuropathic pain and generalised anxiety disorder.
View on EMADuloxetine Zentiva
Treatment depressive disorder, diabetic neuropathic pain, anxiety disorder. Duloxetine Zentiva is indicated in adults.
View on EMADuloxetine Viatris (previously Duloxetine Mylan)
Treatment of major depressive disorder Treatment of diabetic peripheral neuropathic pain Treatment of generalised anxiety disorder Duloxetine Viatris is indicated in adults
View on EMADuloxetine Lilly
Duloxetine Lilly is indicated in adults for: Treatment of major depressive disorder Treatment of diabetic peripheral neuropathic pain Treatment of generalised anxiety disorder Duloxetine Lilly is indicated in adults.
View on EMADuloxetine Boehringer Ingelheim
Treatment of diabetic peripheral neuropathic pain in adults.
View on EMACymbalta
Treatment of major depressive disorder. Treatment of diabetic peripheral neuropathic pain. Treatment of generalised anxiety disorder. Cymbalta is indicated in adults.
View on EMANodetrip (previously Xeristar)
Treatment of major depressive disorder; Treatment of diabetic peripheral neuropathic pain; Treatment of generalised anxiety disorder; Xeristar is indicated in adults.
View on EMAYentreve
Yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (SUI).
View on EMAAriclaim
Treatment of diabetic peripheral neuropathic pain. Ariclaim is indicated in adults.
View on EMA